Cargando…
Pediatric SARS-CoV-2 Seroprevalence, Oregon, USA, November 1, 2020–June 30, 2022
We estimated SARS-CoV-2 seroprevalence in children in Oregon, USA, at 6 time points. Seroprevalence increased linearly during November 2020–December 2021 and peaked in February 2022 at 38.8% (95% CI 32.8%–46.5%). We observed no increase in the seroprevalence trend after widespread school reopening....
Autores principales: | Falender, Rebecca A., Mitchell, Paul G., Guzman-Cottrill, Judith A., Cieslak, Paul R., Sutton, Melissa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370852/ https://www.ncbi.nlm.nih.gov/pubmed/37486347 http://dx.doi.org/10.3201/eid2908.230471 |
Ejemplares similares
-
Comparison of Survey Methods in Norovirus Outbreak Investigation, Oregon, USA, 2009
por: Oh, John Y., et al.
Publicado: (2010) -
Correlation between Clinical and Wastewater SARS-CoV-2 Genomic Surveillance, Oregon, USA
por: Kaya, Devrim, et al.
Publicado: (2022) -
Notes from the Field: Seroprevalence Estimates of SARS-CoV-2 Infection in Convenience Sample — Oregon, May 11–June 15, 2020
por: Sutton, Melissa, et al.
Publicado: (2020) -
Distinguishing Tuberculosis from Nontuberculous Mycobacteria Lung Disease, Oregon, USA
por: Kendall, Brian A., et al.
Publicado: (2011) -
Disseminated Nontuberculous Mycobacteria in HIV-Infected Patients, Oregon, USA, 2007–2012
por: Varley, Cara D., et al.
Publicado: (2017)